PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells

The combination of PD-1 blockade with neoadjuvant chemotherapy (NAC) has achieved unprecedented clinical success in non-small cell lung cancer (NSCLC) compared to NAC alone, but the underlying mechanisms by which PD-1 blockade augments the effects of chemotherapy remain incompletely elucidated. Sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Zhenzhen, Ren, Yulin, Zhang, Dong, Chen, Yulong, Yu, Wenwen, Cao, Jie, Liu, Liang, Wang, Tao, Xiao, Shanshan, Zheng, Liuqing, Pu, Yue, Wei, Feng, You, Jian, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213055/
https://www.ncbi.nlm.nih.gov/pubmed/37231145
http://dx.doi.org/10.1038/s41698-023-00384-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213055/
https://www.ncbi.nlm.nih.gov/pubmed/37231145
http://dx.doi.org/10.1038/s41698-023-00384-x

Ejemplares similares